nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—Sulfacetamide—Dapsone—systemic lupus erythematosus	0.521	1	CrCrCtD
Procainamide—BCHE—Triamcinolone—systemic lupus erythematosus	0.0133	0.769	CbGbCtD
Procainamide—BCHE—diaphragm—systemic lupus erythematosus	0.0124	0.0892	CbGeAlD
Procainamide—DNMT1—connective tissue—systemic lupus erythematosus	0.00311	0.0224	CbGeAlD
Procainamide—SCN9A—nephron tubule—systemic lupus erythematosus	0.00307	0.0222	CbGeAlD
Procainamide—CYP2D6—urine—systemic lupus erythematosus	0.00296	0.0214	CbGeAlD
Procainamide—DNMT1—skin of body—systemic lupus erythematosus	0.00281	0.0203	CbGeAlD
Procainamide—Sunitinib—TYK2—systemic lupus erythematosus	0.0027	0.474	CrCbGaD
Procainamide—SCN11A—nervous system—systemic lupus erythematosus	0.00266	0.0192	CbGeAlD
Procainamide—DNMT1—cortex of kidney—systemic lupus erythematosus	0.00258	0.0186	CbGeAlD
Procainamide—SCN11A—central nervous system—systemic lupus erythematosus	0.00256	0.0185	CbGeAlD
Procainamide—Sunitinib—BLK—systemic lupus erythematosus	0.00254	0.445	CrCbGaD
Procainamide—SLC22A2—nephron tubule—systemic lupus erythematosus	0.00252	0.0182	CbGeAlD
Procainamide—SCN7A—lung—systemic lupus erythematosus	0.00244	0.0176	CbGeAlD
Procainamide—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00241	0.139	CbGbCtD
Procainamide—SCN4A—kidney—systemic lupus erythematosus	0.00241	0.0174	CbGeAlD
Procainamide—SCN10A—nephron tubule—systemic lupus erythematosus	0.00234	0.0169	CbGeAlD
Procainamide—BCHE—blood plasma—systemic lupus erythematosus	0.00233	0.0168	CbGeAlD
Procainamide—DNMT1—lymphoid tissue—systemic lupus erythematosus	0.00227	0.0164	CbGeAlD
Procainamide—SLC22A2—kidney—systemic lupus erythematosus	0.00221	0.016	CbGeAlD
Procainamide—SCN9A—tendon—systemic lupus erythematosus	0.00218	0.0157	CbGeAlD
Procainamide—SLC22A2—cortex of kidney—systemic lupus erythematosus	0.00215	0.0155	CbGeAlD
Procainamide—DNMT1—tendon—systemic lupus erythematosus	0.00214	0.0154	CbGeAlD
Procainamide—SCN2A—cortex of kidney—systemic lupus erythematosus	0.00208	0.015	CbGeAlD
Procainamide—DNMT1—bone marrow—systemic lupus erythematosus	0.00207	0.0149	CbGeAlD
Procainamide—SCN8A—nervous system—systemic lupus erythematosus	0.00202	0.0145	CbGeAlD
Procainamide—SCN4A—tendon—systemic lupus erythematosus	0.00194	0.014	CbGeAlD
Procainamide—SCN8A—central nervous system—systemic lupus erythematosus	0.00194	0.014	CbGeAlD
Procainamide—SCN9A—lung—systemic lupus erythematosus	0.00191	0.0138	CbGeAlD
Procainamide—DNMT1—lung—systemic lupus erythematosus	0.00188	0.0135	CbGeAlD
Procainamide—SCN3A—kidney—systemic lupus erythematosus	0.00187	0.0135	CbGeAlD
Procainamide—SLC22A4—nephron tubule—systemic lupus erythematosus	0.00187	0.0135	CbGeAlD
Procainamide—SCN3A—cortex of kidney—systemic lupus erythematosus	0.00182	0.0132	CbGeAlD
Procainamide—SCN10A—lymphoid tissue—systemic lupus erythematosus	0.00177	0.0127	CbGeAlD
Procainamide—SLC22A3—connective tissue—systemic lupus erythematosus	0.00175	0.0127	CbGeAlD
Procainamide—DNMT1—nervous system—systemic lupus erythematosus	0.00174	0.0125	CbGeAlD
Procainamide—ACHE—tendon—systemic lupus erythematosus	0.00174	0.0125	CbGeAlD
Procainamide—DNMT1—central nervous system—systemic lupus erythematosus	0.00167	0.0121	CbGeAlD
Procainamide—SCN1A—lung—systemic lupus erythematosus	0.00165	0.0119	CbGeAlD
Procainamide—SLC22A4—kidney—systemic lupus erythematosus	0.00164	0.0118	CbGeAlD
Procainamide—SLC22A4—cortex of kidney—systemic lupus erythematosus	0.0016	0.0115	CbGeAlD
Procainamide—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00159	0.0918	CbGbCtD
Procainamide—SCN4A—nervous system—systemic lupus erythematosus	0.00158	0.0114	CbGeAlD
Procainamide—SLC22A1—kidney—systemic lupus erythematosus	0.00156	0.0113	CbGeAlD
Procainamide—CYP2D6—blood plasma—systemic lupus erythematosus	0.00155	0.0112	CbGeAlD
Procainamide—SCN1A—nervous system—systemic lupus erythematosus	0.00152	0.011	CbGeAlD
Procainamide—SCN4A—central nervous system—systemic lupus erythematosus	0.00152	0.011	CbGeAlD
Procainamide—SCN3A—tendon—systemic lupus erythematosus	0.00151	0.0109	CbGeAlD
Procainamide—SLC22A3—kidney—systemic lupus erythematosus	0.00149	0.0108	CbGeAlD
Procainamide—SCN1A—central nervous system—systemic lupus erythematosus	0.00147	0.0106	CbGeAlD
Procainamide—SCN3A—bone marrow—systemic lupus erythematosus	0.00147	0.0106	CbGeAlD
Procainamide—SCN10A—lung—systemic lupus erythematosus	0.00146	0.0105	CbGeAlD
Procainamide—SCN2A—nervous system—systemic lupus erythematosus	0.0014	0.0101	CbGeAlD
Procainamide—SCN10A—nervous system—systemic lupus erythematosus	0.00135	0.00973	CbGeAlD
Procainamide—SCN2A—central nervous system—systemic lupus erythematosus	0.00135	0.00972	CbGeAlD
Procainamide—SCN3A—lung—systemic lupus erythematosus	0.00133	0.00958	CbGeAlD
Procainamide—SLC22A4—tendon—systemic lupus erythematosus	0.00132	0.00956	CbGeAlD
Procainamide—SCN10A—central nervous system—systemic lupus erythematosus	0.0013	0.00937	CbGeAlD
Procainamide—SLC22A4—bone marrow—systemic lupus erythematosus	0.00128	0.00926	CbGeAlD
Procainamide—SLC22A5—nephron tubule—systemic lupus erythematosus	0.00124	0.00891	CbGeAlD
Procainamide—SCN3A—nervous system—systemic lupus erythematosus	0.00123	0.00887	CbGeAlD
Procainamide—SCN5A—nervous system—systemic lupus erythematosus	0.00123	0.00885	CbGeAlD
Procainamide—BCHE—nephron tubule—systemic lupus erythematosus	0.0012	0.00868	CbGeAlD
Procainamide—SCN3A—central nervous system—systemic lupus erythematosus	0.00118	0.00854	CbGeAlD
Procainamide—SCN5A—central nervous system—systemic lupus erythematosus	0.00118	0.00852	CbGeAlD
Procainamide—SLC22A4—lung—systemic lupus erythematosus	0.00116	0.00839	CbGeAlD
Procainamide—SLC22A5—skin of body—systemic lupus erythematosus	0.00115	0.00831	CbGeAlD
Procainamide—BCHE—skin of body—systemic lupus erythematosus	0.00112	0.00809	CbGeAlD
Procainamide—SLC22A5—kidney—systemic lupus erythematosus	0.00109	0.00783	CbGeAlD
Procainamide—SLC22A3—lung—systemic lupus erythematosus	0.00106	0.00763	CbGeAlD
Procainamide—SLC22A5—cortex of kidney—systemic lupus erythematosus	0.00106	0.00763	CbGeAlD
Procainamide—CHRM2—nervous system—systemic lupus erythematosus	0.00104	0.00753	CbGeAlD
Procainamide—SLC22A1—nervous system—systemic lupus erythematosus	0.00102	0.0074	CbGeAlD
Procainamide—CHRM2—central nervous system—systemic lupus erythematosus	0.001	0.00725	CbGeAlD
Procainamide—SLC22A1—central nervous system—systemic lupus erythematosus	0.000987	0.00712	CbGeAlD
Procainamide—SLC22A3—nervous system—systemic lupus erythematosus	0.00098	0.00707	CbGeAlD
Procainamide—SLC22A3—central nervous system—systemic lupus erythematosus	0.000943	0.00681	CbGeAlD
Procainamide—SLC22A5—tendon—systemic lupus erythematosus	0.000876	0.00633	CbGeAlD
Procainamide—BCHE—bone marrow—systemic lupus erythematosus	0.000827	0.00597	CbGeAlD
Procainamide—SLC22A5—lung—systemic lupus erythematosus	0.000769	0.00555	CbGeAlD
Procainamide—BCHE—lung—systemic lupus erythematosus	0.000749	0.00541	CbGeAlD
Procainamide—CYP2D6—kidney—systemic lupus erythematosus	0.0007	0.00505	CbGeAlD
Procainamide—BCHE—nervous system—systemic lupus erythematosus	0.000694	0.00501	CbGeAlD
Procainamide—BCHE—central nervous system—systemic lupus erythematosus	0.000668	0.00482	CbGeAlD
Procainamide—DNMT1—Budesonide—Hydrocortisone—systemic lupus erythematosus	0.000631	0.0762	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Methylprednisolone—systemic lupus erythematosus	0.000595	0.0719	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Dexamethasone—systemic lupus erythematosus	0.000586	0.0708	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Betamethasone—systemic lupus erythematosus	0.000586	0.0708	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Triamcinolone—systemic lupus erythematosus	0.000573	0.0692	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Prednisone—systemic lupus erythematosus	0.000543	0.0656	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Prednisolone—systemic lupus erythematosus	0.00053	0.0641	CbGdCrCtD
Procainamide—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.000512	0.00169	CcSEcCtD
Procainamide—Bradycardia—Betamethasone—systemic lupus erythematosus	0.00051	0.00169	CcSEcCtD
Procainamide—Bradycardia—Dexamethasone—systemic lupus erythematosus	0.00051	0.00169	CcSEcCtD
Procainamide—Neutropenia—Prednisone—systemic lupus erythematosus	0.00051	0.00169	CcSEcCtD
Procainamide—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000509	0.00168	CcSEcCtD
Procainamide—Abdominal pain—Azathioprine—systemic lupus erythematosus	0.000509	0.00168	CcSEcCtD
Procainamide—Malaise—Mycophenolate mofetil—systemic lupus erythematosus	0.000506	0.00167	CcSEcCtD
Procainamide—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000501	0.00166	CcSEcCtD
Procainamide—Hallucination—Betamethasone—systemic lupus erythematosus	0.000499	0.00165	CcSEcCtD
Procainamide—Hallucination—Dexamethasone—systemic lupus erythematosus	0.000499	0.00165	CcSEcCtD
Procainamide—Convulsion—Cyclosporine—systemic lupus erythematosus	0.000498	0.00165	CcSEcCtD
Procainamide—Gastrointestinal pain—Leflunomide—systemic lupus erythematosus	0.000497	0.00165	CcSEcCtD
Procainamide—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.000489	0.00162	CcSEcCtD
Procainamide—Myalgia—Cyclosporine—systemic lupus erythematosus	0.000489	0.00162	CcSEcCtD
Procainamide—Convulsion—Mycophenolate mofetil—systemic lupus erythematosus	0.000486	0.00161	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisolone—systemic lupus erythematosus	0.000485	0.00161	CcSEcCtD
Procainamide—Depression—Prednisone—systemic lupus erythematosus	0.000485	0.00161	CcSEcCtD
Procainamide—Discomfort—Cyclosporine—systemic lupus erythematosus	0.000484	0.0016	CcSEcCtD
Procainamide—Urticaria—Leflunomide—systemic lupus erythematosus	0.000483	0.0016	CcSEcCtD
Procainamide—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000481	0.00159	CcSEcCtD
Procainamide—Abdominal pain—Leflunomide—systemic lupus erythematosus	0.000481	0.00159	CcSEcCtD
Procainamide—Angioedema—Prednisolone—systemic lupus erythematosus	0.000478	0.00158	CcSEcCtD
Procainamide—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000477	0.00158	CcSEcCtD
Procainamide—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.000477	0.00158	CcSEcCtD
Procainamide—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000474	0.00157	CcSEcCtD
Procainamide—Ill-defined disorder—Hydrocortisone—systemic lupus erythematosus	0.000474	0.00157	CcSEcCtD
Procainamide—Confusional state—Cyclosporine—systemic lupus erythematosus	0.000473	0.00157	CcSEcCtD
Procainamide—Malaise—Prednisolone—systemic lupus erythematosus	0.000472	0.00156	CcSEcCtD
Procainamide—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000472	0.00156	CcSEcCtD
Procainamide—Dysgeusia—Triamcinolone—systemic lupus erythematosus	0.000471	0.00156	CcSEcCtD
Procainamide—Angioedema—Hydrocortisone—systemic lupus erythematosus	0.000467	0.00155	CcSEcCtD
Procainamide—Confusional state—Mycophenolate mofetil—systemic lupus erythematosus	0.000462	0.00153	CcSEcCtD
Procainamide—Malaise—Hydrocortisone—systemic lupus erythematosus	0.000461	0.00152	CcSEcCtD
Procainamide—Probenecid—ALB—systemic lupus erythematosus	0.00046	0.0809	CrCbGaD
Procainamide—CYP2D6—nervous system—systemic lupus erythematosus	0.00046	0.00332	CbGeAlD
Procainamide—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000459	0.00152	CcSEcCtD
Procainamide—Convulsion—Prednisolone—systemic lupus erythematosus	0.000453	0.0015	CcSEcCtD
Procainamide—Eosinophilia—Methotrexate—systemic lupus erythematosus	0.000451	0.00149	CcSEcCtD
Procainamide—Shock—Mycophenolate mofetil—systemic lupus erythematosus	0.00045	0.00149	CcSEcCtD
Procainamide—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000448	0.00148	CcSEcCtD
Procainamide—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000448	0.00148	CcSEcCtD
Procainamide—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000447	0.00148	CcSEcCtD
Procainamide—Ill-defined disorder—Triamcinolone—systemic lupus erythematosus	0.000446	0.00148	CcSEcCtD
Procainamide—Ill-defined disorder—Methylprednisolone—systemic lupus erythematosus	0.000445	0.00147	CcSEcCtD
Procainamide—Bradycardia—Prednisone—systemic lupus erythematosus	0.000445	0.00147	CcSEcCtD
Procainamide—Convulsion—Hydrocortisone—systemic lupus erythematosus	0.000443	0.00147	CcSEcCtD
Procainamide—CYP2D6—central nervous system—systemic lupus erythematosus	0.000442	0.00319	CbGeAlD
Procainamide—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.00044	0.00146	CcSEcCtD
Procainamide—Discomfort—Prednisolone—systemic lupus erythematosus	0.00044	0.00146	CcSEcCtD
Procainamide—Angioedema—Triamcinolone—systemic lupus erythematosus	0.00044	0.00145	CcSEcCtD
Procainamide—Angioedema—Methylprednisolone—systemic lupus erythematosus	0.000439	0.00145	CcSEcCtD
Procainamide—Abdominal discomfort—Methotrexate—systemic lupus erythematosus	0.000437	0.00145	CcSEcCtD
Procainamide—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000436	0.00144	CcSEcCtD
Procainamide—Asthenia—Leflunomide—systemic lupus erythematosus	0.000436	0.00144	CcSEcCtD
Procainamide—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000435	0.00144	CcSEcCtD
Procainamide—Hallucination—Prednisone—systemic lupus erythematosus	0.000435	0.00144	CcSEcCtD
Procainamide—Malaise—Triamcinolone—systemic lupus erythematosus	0.000434	0.00144	CcSEcCtD
Procainamide—Malaise—Methylprednisolone—systemic lupus erythematosus	0.000433	0.00143	CcSEcCtD
Procainamide—Pruritus—Leflunomide—systemic lupus erythematosus	0.00043	0.00142	CcSEcCtD
Procainamide—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.00043	0.00142	CcSEcCtD
Procainamide—Hypotension—Mycophenolate mofetil—systemic lupus erythematosus	0.000428	0.00142	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000427	0.00141	CcSEcCtD
Procainamide—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000426	0.00141	CcSEcCtD
Procainamide—Dizziness—Azathioprine—systemic lupus erythematosus	0.000426	0.00141	CcSEcCtD
Procainamide—Shock—Prednisolone—systemic lupus erythematosus	0.00042	0.00139	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000417	0.00138	CcSEcCtD
Procainamide—Convulsion—Triamcinolone—systemic lupus erythematosus	0.000417	0.00138	CcSEcCtD
Procainamide—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000416	0.00138	CcSEcCtD
Procainamide—Convulsion—Methylprednisolone—systemic lupus erythematosus	0.000416	0.00138	CcSEcCtD
Procainamide—Shock—Hydrocortisone—systemic lupus erythematosus	0.00041	0.00136	CcSEcCtD
Procainamide—Myalgia—Triamcinolone—systemic lupus erythematosus	0.00041	0.00136	CcSEcCtD
Procainamide—Vomiting—Azathioprine—systemic lupus erythematosus	0.000409	0.00135	CcSEcCtD
Procainamide—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000409	0.00135	CcSEcCtD
Procainamide—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000409	0.00135	CcSEcCtD
Procainamide—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000408	0.00135	CcSEcCtD
Procainamide—Depression—Methotrexate—systemic lupus erythematosus	0.000405	0.00134	CcSEcCtD
Procainamide—Flushing—Prednisone—systemic lupus erythematosus	0.000405	0.00134	CcSEcCtD
Procainamide—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	0.000405	0.00134	CcSEcCtD
Procainamide—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	0.000405	0.00134	CcSEcCtD
Procainamide—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000405	0.00134	CcSEcCtD
Procainamide—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000404	0.00134	CcSEcCtD
Procainamide—Dizziness—Leflunomide—systemic lupus erythematosus	0.000402	0.00133	CcSEcCtD
Procainamide—Renal failure—Methotrexate—systemic lupus erythematosus	0.0004	0.00132	CcSEcCtD
Procainamide—Angioedema—Betamethasone—systemic lupus erythematosus	0.000399	0.00132	CcSEcCtD
Procainamide—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000399	0.00132	CcSEcCtD
Procainamide—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000398	0.00132	CcSEcCtD
Procainamide—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000397	0.00132	CcSEcCtD
Procainamide—Confusional state—Methylprednisolone—systemic lupus erythematosus	0.000395	0.00131	CcSEcCtD
Procainamide—Malaise—Dexamethasone—systemic lupus erythematosus	0.000394	0.0013	CcSEcCtD
Procainamide—Malaise—Betamethasone—systemic lupus erythematosus	0.000394	0.0013	CcSEcCtD
Procainamide—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.00039	0.00129	CcSEcCtD
Procainamide—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000387	0.00128	CcSEcCtD
Procainamide—Vomiting—Leflunomide—systemic lupus erythematosus	0.000387	0.00128	CcSEcCtD
Procainamide—Shock—Triamcinolone—systemic lupus erythematosus	0.000386	0.00128	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	0.000386	0.0466	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Hydrocortisone—systemic lupus erythematosus	0.000386	0.0466	CbGdCrCtD
Procainamide—Shock—Methylprednisolone—systemic lupus erythematosus	0.000385	0.00128	CcSEcCtD
Procainamide—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000384	0.00127	CcSEcCtD
Procainamide—Nausea—Azathioprine—systemic lupus erythematosus	0.000382	0.00127	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.00038	0.00126	CcSEcCtD
Procainamide—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000379	0.00126	CcSEcCtD
Procainamide—Convulsion—Dexamethasone—systemic lupus erythematosus	0.000378	0.00125	CcSEcCtD
Procainamide—Convulsion—Betamethasone—systemic lupus erythematosus	0.000378	0.00125	CcSEcCtD
Procainamide—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000377	0.00125	CcSEcCtD
Procainamide—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000374	0.00124	CcSEcCtD
Procainamide—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000373	0.00123	CcSEcCtD
Procainamide—Myalgia—Betamethasone—systemic lupus erythematosus	0.000372	0.00123	CcSEcCtD
Procainamide—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000372	0.00123	CcSEcCtD
Procainamide—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000371	0.00123	CcSEcCtD
Procainamide—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000371	0.00123	CcSEcCtD
Procainamide—Discomfort—Betamethasone—systemic lupus erythematosus	0.000367	0.00122	CcSEcCtD
Procainamide—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000367	0.00122	CcSEcCtD
Procainamide—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000366	0.00121	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	0.000364	0.044	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Methylprednisolone—systemic lupus erythematosus	0.000364	0.044	CbGdCrCtD
Procainamide—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000364	0.0012	CcSEcCtD
Procainamide—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000362	0.0012	CcSEcCtD
Procainamide—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000362	0.0012	CcSEcCtD
Procainamide—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000362	0.0012	CcSEcCtD
Procainamide—Nausea—Leflunomide—systemic lupus erythematosus	0.000361	0.0012	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Dexamethasone—systemic lupus erythematosus	0.000359	0.0433	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Betamethasone—systemic lupus erythematosus	0.000359	0.0433	CbGdCrCtD
Procainamide—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000358	0.00118	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000357	0.00118	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000353	0.00117	CcSEcCtD
Procainamide—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000352	0.00116	CcSEcCtD
Procainamide—Shock—Dexamethasone—systemic lupus erythematosus	0.000351	0.00116	CcSEcCtD
Procainamide—Shock—Betamethasone—systemic lupus erythematosus	0.000351	0.00116	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Triamcinolone—systemic lupus erythematosus	0.00035	0.0423	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Triamcinolone—systemic lupus erythematosus	0.00035	0.0423	CbGdCrCtD
Procainamide—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000349	0.00115	CcSEcCtD
Procainamide—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000349	0.00115	CcSEcCtD
Procainamide—Angioedema—Prednisone—systemic lupus erythematosus	0.000347	0.00115	CcSEcCtD
Procainamide—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000346	0.00114	CcSEcCtD
Procainamide—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000344	0.00114	CcSEcCtD
Procainamide—Malaise—Prednisone—systemic lupus erythematosus	0.000343	0.00113	CcSEcCtD
Procainamide—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000341	0.00113	CcSEcCtD
Procainamide—Anorexia—Dexamethasone—systemic lupus erythematosus	0.00034	0.00112	CcSEcCtD
Procainamide—Anorexia—Betamethasone—systemic lupus erythematosus	0.00034	0.00112	CcSEcCtD
Procainamide—Urticaria—Prednisolone—systemic lupus erythematosus	0.000339	0.00112	CcSEcCtD
Procainamide—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000339	0.00112	CcSEcCtD
Procainamide—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000337	0.00112	CcSEcCtD
Procainamide—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000337	0.00111	CcSEcCtD
Procainamide—Hypotension—Betamethasone—systemic lupus erythematosus	0.000333	0.0011	CcSEcCtD
Procainamide—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000333	0.0011	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisone—systemic lupus erythematosus	0.000332	0.0402	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisone—systemic lupus erythematosus	0.000332	0.0402	CbGdCrCtD
Procainamide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000332	0.0011	CcSEcCtD
Procainamide—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000331	0.0011	CcSEcCtD
Procainamide—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.00033	0.00109	CcSEcCtD
Procainamide—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.00033	0.00109	CcSEcCtD
Procainamide—Convulsion—Prednisone—systemic lupus erythematosus	0.000329	0.00109	CcSEcCtD
Procainamide—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000328	0.00109	CcSEcCtD
Procainamide—Chills—Methotrexate—systemic lupus erythematosus	0.000327	0.00108	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000325	0.00107	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000325	0.00107	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Prednisolone—systemic lupus erythematosus	0.000324	0.0392	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Prednisolone—systemic lupus erythematosus	0.000324	0.0392	CbGdCrCtD
Procainamide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000324	0.00107	CcSEcCtD
Procainamide—Myalgia—Prednisone—systemic lupus erythematosus	0.000324	0.00107	CcSEcCtD
Procainamide—Arthralgia—Prednisone—systemic lupus erythematosus	0.000324	0.00107	CcSEcCtD
Procainamide—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000324	0.00107	CcSEcCtD
Procainamide—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000323	0.00107	CcSEcCtD
Procainamide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000321	0.00106	CcSEcCtD
Procainamide—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.00032	0.00106	CcSEcCtD
Procainamide—Discomfort—Prednisone—systemic lupus erythematosus	0.00032	0.00106	CcSEcCtD
Procainamide—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000315	0.00104	CcSEcCtD
Procainamide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000313	0.00104	CcSEcCtD
Procainamide—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000312	0.00103	CcSEcCtD
Procainamide—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000311	0.00103	CcSEcCtD
Procainamide—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000311	0.00103	CcSEcCtD
Procainamide—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.00031	0.00103	CcSEcCtD
Procainamide—Dizziness—Cyclosporine—systemic lupus erythematosus	0.00031	0.00103	CcSEcCtD
Procainamide—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.00031	0.00102	CcSEcCtD
Procainamide—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.00031	0.00102	CcSEcCtD
Procainamide—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.00031	0.00102	CcSEcCtD
Procainamide—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000307	0.00102	CcSEcCtD
Procainamide—Shock—Prednisone—systemic lupus erythematosus	0.000305	0.00101	CcSEcCtD
Procainamide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000303	0.001	CcSEcCtD
Procainamide—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000299	0.00099	CcSEcCtD
Procainamide—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000298	0.000987	CcSEcCtD
Procainamide—Anorexia—Prednisone—systemic lupus erythematosus	0.000296	0.000979	CcSEcCtD
Procainamide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000295	0.000976	CcSEcCtD
Procainamide—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000295	0.000976	CcSEcCtD
Procainamide—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000294	0.000972	CcSEcCtD
Procainamide—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000294	0.000972	CcSEcCtD
Procainamide—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000291	0.000964	CcSEcCtD
Procainamide—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000291	0.000964	CcSEcCtD
Procainamide—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000291	0.000963	CcSEcCtD
Procainamide—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000289	0.000957	CcSEcCtD
Procainamide—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000289	0.000955	CcSEcCtD
Procainamide—Malaise—Methotrexate—systemic lupus erythematosus	0.000287	0.000948	CcSEcCtD
Procainamide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000285	0.000944	CcSEcCtD
Procainamide—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000283	0.000937	CcSEcCtD
Procainamide—Urticaria—Betamethasone—systemic lupus erythematosus	0.000283	0.000937	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000283	0.000936	CcSEcCtD
Procainamide—Dizziness—Prednisolone—systemic lupus erythematosus	0.000282	0.000934	CcSEcCtD
Procainamide—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000282	0.000932	CcSEcCtD
Procainamide—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000282	0.000932	CcSEcCtD
Procainamide—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000282	0.000932	CcSEcCtD
Procainamide—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000282	0.000932	CcSEcCtD
Procainamide—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000282	0.000932	CcSEcCtD
Procainamide—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000281	0.00093	CcSEcCtD
Procainamide—Nausea—Cyclosporine—systemic lupus erythematosus	0.000279	0.000922	CcSEcCtD
Procainamide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000278	0.000919	CcSEcCtD
Procainamide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000277	0.000917	CcSEcCtD
Procainamide—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000276	0.000913	CcSEcCtD
Procainamide—Convulsion—Methotrexate—systemic lupus erythematosus	0.000275	0.000911	CcSEcCtD
Procainamide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000272	0.0009	CcSEcCtD
Procainamide—Arthralgia—Methotrexate—systemic lupus erythematosus	0.00027	0.000895	CcSEcCtD
Procainamide—Myalgia—Methotrexate—systemic lupus erythematosus	0.00027	0.000895	CcSEcCtD
Procainamide—Decreased appetite—Prednisone—systemic lupus erythematosus	0.00027	0.000893	CcSEcCtD
Procainamide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000268	0.000887	CcSEcCtD
Procainamide—Discomfort—Methotrexate—systemic lupus erythematosus	0.000267	0.000884	CcSEcCtD
Procainamide—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000265	0.000877	CcSEcCtD
Procainamide—Confusional state—Methotrexate—systemic lupus erythematosus	0.000261	0.000865	CcSEcCtD
Procainamide—Dizziness—Triamcinolone—systemic lupus erythematosus	0.00026	0.000859	CcSEcCtD
Procainamide—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000259	0.000857	CcSEcCtD
Procainamide—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000256	0.000846	CcSEcCtD
Procainamide—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000256	0.000846	CcSEcCtD
Procainamide—Asthenia—Betamethasone—systemic lupus erythematosus	0.000256	0.000846	CcSEcCtD
Procainamide—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000254	0.00084	CcSEcCtD
Procainamide—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000254	0.00084	CcSEcCtD
Procainamide—Nausea—Prednisolone—systemic lupus erythematosus	0.000254	0.000839	CcSEcCtD
Procainamide—Pruritus—Betamethasone—systemic lupus erythematosus	0.000252	0.000834	CcSEcCtD
Procainamide—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000252	0.000834	CcSEcCtD
Procainamide—Vomiting—Triamcinolone—systemic lupus erythematosus	0.00025	0.000826	CcSEcCtD
Procainamide—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000249	0.000824	CcSEcCtD
Procainamide—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000248	0.00082	CcSEcCtD
Procainamide—Anorexia—Methotrexate—systemic lupus erythematosus	0.000247	0.000818	CcSEcCtD
Procainamide—Urticaria—Prednisone—systemic lupus erythematosus	0.000246	0.000816	CcSEcCtD
Procainamide—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000245	0.000812	CcSEcCtD
Procainamide—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000245	0.000812	CcSEcCtD
Procainamide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000244	0.000807	CcSEcCtD
Procainamide—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000244	0.000807	CcSEcCtD
Procainamide—Hypotension—Methotrexate—systemic lupus erythematosus	0.000242	0.000802	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000236	0.000782	CcSEcCtD
Procainamide—Dizziness—Betamethasone—systemic lupus erythematosus	0.000236	0.00078	CcSEcCtD
Procainamide—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000236	0.00078	CcSEcCtD
Procainamide—Nausea—Triamcinolone—systemic lupus erythematosus	0.000233	0.000772	CcSEcCtD
Procainamide—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000233	0.00077	CcSEcCtD
Procainamide—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000229	0.000757	CcSEcCtD
Procainamide—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000227	0.00075	CcSEcCtD
Procainamide—Vomiting—Betamethasone—systemic lupus erythematosus	0.000227	0.00075	CcSEcCtD
Procainamide—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000225	0.000746	CcSEcCtD
Procainamide—Asthenia—Prednisone—systemic lupus erythematosus	0.000223	0.000737	CcSEcCtD
Procainamide—Pruritus—Prednisone—systemic lupus erythematosus	0.00022	0.000726	CcSEcCtD
Procainamide—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000214	0.000707	CcSEcCtD
Procainamide—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000212	0.000703	CcSEcCtD
Procainamide—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000212	0.000702	CcSEcCtD
Procainamide—Nausea—Betamethasone—systemic lupus erythematosus	0.000212	0.0007	CcSEcCtD
Procainamide—Nausea—Dexamethasone—systemic lupus erythematosus	0.000212	0.0007	CcSEcCtD
Procainamide—Urticaria—Methotrexate—systemic lupus erythematosus	0.000206	0.000682	CcSEcCtD
Procainamide—Dizziness—Prednisone—systemic lupus erythematosus	0.000205	0.000679	CcSEcCtD
Procainamide—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000205	0.000678	CcSEcCtD
Procainamide—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000205	0.000678	CcSEcCtD
Procainamide—Vomiting—Prednisone—systemic lupus erythematosus	0.000197	0.000653	CcSEcCtD
Procainamide—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000191	0.000632	CcSEcCtD
Procainamide—Asthenia—Methotrexate—systemic lupus erythematosus	0.000186	0.000616	CcSEcCtD
Procainamide—Nausea—Prednisone—systemic lupus erythematosus	0.000184	0.00061	CcSEcCtD
Procainamide—Pruritus—Methotrexate—systemic lupus erythematosus	0.000183	0.000607	CcSEcCtD
Procainamide—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000177	0.000587	CcSEcCtD
Procainamide—Dizziness—Methotrexate—systemic lupus erythematosus	0.000171	0.000567	CcSEcCtD
Procainamide—Vomiting—Methotrexate—systemic lupus erythematosus	0.000165	0.000546	CcSEcCtD
Procainamide—Nausea—Methotrexate—systemic lupus erythematosus	0.000154	0.00051	CcSEcCtD
Procainamide—SCN9A—Axon guidance—MMP9—systemic lupus erythematosus	1.26e-05	0.00174	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—P2RY12—systemic lupus erythematosus	1.26e-05	0.00173	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—PPARG—systemic lupus erythematosus	1.25e-05	0.00172	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—VEGFA—systemic lupus erythematosus	1.23e-05	0.00169	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—MMP9—systemic lupus erythematosus	1.22e-05	0.00167	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—RXRA—systemic lupus erythematosus	1.21e-05	0.00167	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—MMP9—systemic lupus erythematosus	1.21e-05	0.00166	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—PPARG—systemic lupus erythematosus	1.2e-05	0.00165	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—PPARG—systemic lupus erythematosus	1.2e-05	0.00165	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—IL6—systemic lupus erythematosus	1.19e-05	0.00163	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—F2—systemic lupus erythematosus	1.18e-05	0.00163	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.18e-05	0.00162	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.17e-05	0.00161	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—MMP9—systemic lupus erythematosus	1.16e-05	0.00159	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—MMP9—systemic lupus erythematosus	1.16e-05	0.00159	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—PPARG—systemic lupus erythematosus	1.16e-05	0.00159	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—PPARG—systemic lupus erythematosus	1.16e-05	0.00159	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EP300—systemic lupus erythematosus	1.15e-05	0.00159	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TYK2—systemic lupus erythematosus	1.14e-05	0.00157	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—VEGFA—systemic lupus erythematosus	1.13e-05	0.00156	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TGFB1—systemic lupus erythematosus	1.12e-05	0.00155	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—MMP9—systemic lupus erythematosus	1.12e-05	0.00154	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—MMP9—systemic lupus erythematosus	1.12e-05	0.00154	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—MMP9—systemic lupus erythematosus	1.11e-05	0.00153	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	1.11e-05	0.00153	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—VDR—systemic lupus erythematosus	1.1e-05	0.00151	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TYK2—systemic lupus erythematosus	1.09e-05	0.0015	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—VEGFA—systemic lupus erythematosus	1.09e-05	0.0015	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	1.08e-05	0.00149	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—VEGFA—systemic lupus erythematosus	1.08e-05	0.00149	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—JAK1—systemic lupus erythematosus	1.08e-05	0.00149	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—IL6—systemic lupus erythematosus	1.06e-05	0.00146	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EP300—systemic lupus erythematosus	1.05e-05	0.00145	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.05e-05	0.00145	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TNF—systemic lupus erythematosus	1.05e-05	0.00145	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.05e-05	0.00145	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TYK2—systemic lupus erythematosus	1.05e-05	0.00145	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TYK2—systemic lupus erythematosus	1.05e-05	0.00145	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—VEGFA—systemic lupus erythematosus	1.04e-05	0.00143	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—VEGFA—systemic lupus erythematosus	1.04e-05	0.00143	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	1.04e-05	0.00143	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TYK2—systemic lupus erythematosus	1.01e-05	0.00139	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TYK2—systemic lupus erythematosus	1.01e-05	0.00139	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—VEGFA—systemic lupus erythematosus	1e-05	0.00138	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—VEGFA—systemic lupus erythematosus	1e-05	0.00138	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TGFB1—systemic lupus erythematosus	1e-05	0.00138	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—VEGFA—systemic lupus erythematosus	9.99e-06	0.00137	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—TYK2—systemic lupus erythematosus	9.97e-06	0.00137	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NR3C1—systemic lupus erythematosus	9.89e-06	0.00136	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.82e-06	0.00135	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—IL6—systemic lupus erythematosus	9.68e-06	0.00133	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	9.58e-06	0.00132	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TNF—systemic lupus erythematosus	9.36e-06	0.00129	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—C3—systemic lupus erythematosus	9.36e-06	0.00129	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	9.31e-06	0.00128	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TGFB1—systemic lupus erythematosus	9.17e-06	0.00126	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	9.07e-06	0.00125	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MMP9—systemic lupus erythematosus	8.99e-06	0.00124	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	8.89e-06	0.00122	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NAT2—systemic lupus erythematosus	8.8e-06	0.00121	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—ACE—systemic lupus erythematosus	8.79e-06	0.00121	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	8.75e-06	0.0012	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.72e-06	0.0012	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	8.63e-06	0.00119	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MMP9—systemic lupus erythematosus	8.6e-06	0.00118	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TNF—systemic lupus erythematosus	8.56e-06	0.00118	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EP300—systemic lupus erythematosus	8.53e-06	0.00117	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—IL6—systemic lupus erythematosus	8.47e-06	0.00117	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL12—systemic lupus erythematosus	8.46e-06	0.00116	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MMP9—systemic lupus erythematosus	8.27e-06	0.00114	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MMP9—systemic lupus erythematosus	8.27e-06	0.00114	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	8.17e-06	0.00112	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EP300—systemic lupus erythematosus	8.16e-06	0.00112	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—PPARG—systemic lupus erythematosus	8.12e-06	0.00112	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VEGFA—systemic lupus erythematosus	8.08e-06	0.00111	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MMP9—systemic lupus erythematosus	7.97e-06	0.0011	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MMP9—systemic lupus erythematosus	7.97e-06	0.0011	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	7.93e-06	0.00109	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MMP9—systemic lupus erythematosus	7.85e-06	0.00108	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—ACE—systemic lupus erythematosus	7.84e-06	0.00108	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EP300—systemic lupus erythematosus	7.84e-06	0.00108	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EP300—systemic lupus erythematosus	7.84e-06	0.00108	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—IL6—systemic lupus erythematosus	7.83e-06	0.00108	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.78e-06	0.00107	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VEGFA—systemic lupus erythematosus	7.73e-06	0.00106	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—PPARG—systemic lupus erythematosus	7.66e-06	0.00106	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	7.61e-06	0.00105	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EP300—systemic lupus erythematosus	7.56e-06	0.00104	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EP300—systemic lupus erythematosus	7.56e-06	0.00104	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—IL6—systemic lupus erythematosus	7.55e-06	0.00104	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.5e-06	0.00103	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—IL6—systemic lupus erythematosus	7.49e-06	0.00103	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	7.44e-06	0.00102	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—systemic lupus erythematosus	7.42e-06	0.00102	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—systemic lupus erythematosus	7.42e-06	0.00102	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TGFB1—systemic lupus erythematosus	7.41e-06	0.00102	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	7.38e-06	0.00102	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—IL6—systemic lupus erythematosus	7.19e-06	0.00099	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—IL6—systemic lupus erythematosus	7.19e-06	0.00099	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—systemic lupus erythematosus	7.16e-06	0.000985	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—systemic lupus erythematosus	7.16e-06	0.000985	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TYK2—systemic lupus erythematosus	7.12e-06	0.00098	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	7.1e-06	0.000978	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TGFB1—systemic lupus erythematosus	7.09e-06	0.000976	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—systemic lupus erythematosus	7.05e-06	0.000971	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	7e-06	0.000964	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—IL6—systemic lupus erythematosus	6.94e-06	0.000955	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—IL6—systemic lupus erythematosus	6.94e-06	0.000955	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NAT2—systemic lupus erythematosus	6.93e-06	0.000954	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—systemic lupus erythematosus	6.92e-06	0.000953	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—IL6—systemic lupus erythematosus	6.91e-06	0.000951	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	6.89e-06	0.000949	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.88e-06	0.000947	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TGFB1—systemic lupus erythematosus	6.81e-06	0.000938	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TGFB1—systemic lupus erythematosus	6.81e-06	0.000938	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—systemic lupus erythematosus	6.62e-06	0.000912	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.61e-06	0.00091	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TGFB1—systemic lupus erythematosus	6.57e-06	0.000904	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TGFB1—systemic lupus erythematosus	6.57e-06	0.000904	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	6.53e-06	0.000899	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	6.53e-06	0.000899	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—P2RY12—systemic lupus erythematosus	6.45e-06	0.000888	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—systemic lupus erythematosus	6.36e-06	0.000876	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—systemic lupus erythematosus	6.36e-06	0.000876	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NAT2—systemic lupus erythematosus	6.18e-06	0.000851	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.16e-06	0.000848	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—systemic lupus erythematosus	6.13e-06	0.000845	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—systemic lupus erythematosus	6.13e-06	0.000845	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.98e-06	0.000823	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.96e-06	0.000821	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	5.82e-06	0.000802	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCR5—systemic lupus erythematosus	5.8e-06	0.000798	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—C3—systemic lupus erythematosus	5.67e-06	0.00078	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP9—systemic lupus erythematosus	5.6e-06	0.000771	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	5.59e-06	0.00077	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—IL6—systemic lupus erythematosus	5.59e-06	0.000769	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NAT2—systemic lupus erythematosus	5.52e-06	0.00076	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.51e-06	0.000758	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—systemic lupus erythematosus	5.34e-06	0.000736	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EP300—systemic lupus erythematosus	5.31e-06	0.000731	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—F2—systemic lupus erythematosus	5.15e-06	0.000709	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NAT2—systemic lupus erythematosus	5.14e-06	0.000708	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—systemic lupus erythematosus	5.13e-06	0.000707	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—systemic lupus erythematosus	5.13e-06	0.000707	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—systemic lupus erythematosus	5.03e-06	0.000693	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—F2—systemic lupus erythematosus	4.97e-06	0.000685	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.95e-06	0.000682	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—systemic lupus erythematosus	4.95e-06	0.000682	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—systemic lupus erythematosus	4.95e-06	0.000682	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—RXRA—systemic lupus erythematosus	4.93e-06	0.000679	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.91e-06	0.000676	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—systemic lupus erythematosus	4.88e-06	0.000671	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	4.78e-06	0.000658	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—systemic lupus erythematosus	4.62e-06	0.000636	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—F2—systemic lupus erythematosus	4.6e-06	0.000633	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CCL2—systemic lupus erythematosus	4.59e-06	0.000632	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	4.51e-06	0.000621	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	4.46e-06	0.000614	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCL2—systemic lupus erythematosus	4.43e-06	0.00061	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.42e-06	0.000608	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL12—systemic lupus erythematosus	4.34e-06	0.000598	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.33e-06	0.000596	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—systemic lupus erythematosus	4.31e-06	0.000594	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CCL2—systemic lupus erythematosus	4.1e-06	0.000564	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	4.05e-06	0.000557	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TLR9—systemic lupus erythematosus	3.94e-06	0.000542	CbGpPWpGaD
Procainamide—ACHE—Metabolism—RXRA—systemic lupus erythematosus	3.88e-06	0.000535	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.86e-06	0.000532	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—P2RY12—systemic lupus erythematosus	3.81e-06	0.000525	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.75e-06	0.000516	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.6e-06	0.000496	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	3.6e-06	0.000496	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CSK—systemic lupus erythematosus	3.51e-06	0.000483	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.5e-06	0.000481	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—systemic lupus erythematosus	3.48e-06	0.000479	CbGpPWpGaD
Procainamide—BCHE—Metabolism—RXRA—systemic lupus erythematosus	3.46e-06	0.000477	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—JAK1—systemic lupus erythematosus	3.46e-06	0.000476	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CCR5—systemic lupus erythematosus	3.28e-06	0.000451	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	3.23e-06	0.000445	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.21e-06	0.000442	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NCF2—systemic lupus erythematosus	3.21e-06	0.000442	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—C3—systemic lupus erythematosus	3.2e-06	0.000441	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LYN—systemic lupus erythematosus	3.19e-06	0.000439	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—JAK1—systemic lupus erythematosus	3.14e-06	0.000432	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SH2B3—systemic lupus erythematosus	3.13e-06	0.00043	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PPARG—systemic lupus erythematosus	3.11e-06	0.000429	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—RXRA—systemic lupus erythematosus	3.09e-06	0.000426	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCR5—systemic lupus erythematosus	2.98e-06	0.00041	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2RA—systemic lupus erythematosus	2.93e-06	0.000404	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—C3—systemic lupus erythematosus	2.91e-06	0.0004	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—RXRA—systemic lupus erythematosus	2.88e-06	0.000397	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	2.84e-06	0.000391	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—F2—systemic lupus erythematosus	2.81e-06	0.000387	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—systemic lupus erythematosus	2.8e-06	0.000386	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—systemic lupus erythematosus	2.68e-06	0.000369	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL12—systemic lupus erythematosus	2.56e-06	0.000353	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—F2—systemic lupus erythematosus	2.55e-06	0.000351	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JUNB—systemic lupus erythematosus	2.52e-06	0.000347	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PPARG—systemic lupus erythematosus	2.45e-06	0.000338	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTGS2—systemic lupus erythematosus	2.45e-06	0.000337	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RASGRP1—systemic lupus erythematosus	2.39e-06	0.000329	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRL—systemic lupus erythematosus	2.32e-06	0.000319	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.28e-06	0.000313	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—systemic lupus erythematosus	2.2e-06	0.000304	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PPARG—systemic lupus erythematosus	2.19e-06	0.000301	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—systemic lupus erythematosus	2.11e-06	0.00029	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.07e-06	0.000284	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—EP300—systemic lupus erythematosus	2.04e-06	0.000281	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—systemic lupus erythematosus	1.97e-06	0.000271	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PPARG—systemic lupus erythematosus	1.95e-06	0.000269	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTGS2—systemic lupus erythematosus	1.93e-06	0.000266	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—systemic lupus erythematosus	1.89e-06	0.000261	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—systemic lupus erythematosus	1.88e-06	0.000259	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—JAK1—systemic lupus erythematosus	1.85e-06	0.000255	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PPARG—systemic lupus erythematosus	1.82e-06	0.000251	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCR5—systemic lupus erythematosus	1.76e-06	0.000242	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—systemic lupus erythematosus	1.76e-06	0.000242	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.73e-06	0.000239	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTGS2—systemic lupus erythematosus	1.72e-06	0.000237	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—systemic lupus erythematosus	1.72e-06	0.000237	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—C3—systemic lupus erythematosus	1.72e-06	0.000236	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—systemic lupus erythematosus	1.68e-06	0.000231	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—systemic lupus erythematosus	1.64e-06	0.000225	CbGpPWpGaD
Procainamide—ACHE—Metabolism—EP300—systemic lupus erythematosus	1.6e-06	0.000221	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	1.59e-06	0.000219	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—systemic lupus erythematosus	1.57e-06	0.000216	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTGS2—systemic lupus erythematosus	1.54e-06	0.000212	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—F2—systemic lupus erythematosus	1.51e-06	0.000208	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CD80—systemic lupus erythematosus	1.45e-06	0.000199	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTGS2—systemic lupus erythematosus	1.43e-06	0.000197	CbGpPWpGaD
Procainamide—BCHE—Metabolism—EP300—systemic lupus erythematosus	1.43e-06	0.000197	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.34e-06	0.000185	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—EP300—systemic lupus erythematosus	1.28e-06	0.000176	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.22e-06	0.000168	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.2e-06	0.000165	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—EP300—systemic lupus erythematosus	1.19e-06	0.000164	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.04e-06	0.000143	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—systemic lupus erythematosus	1.02e-06	0.00014	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—systemic lupus erythematosus	1.01e-06	0.000139	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	1.01e-06	0.000138	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—systemic lupus erythematosus	9.61e-07	0.000132	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	9.58e-07	0.000132	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EP300—systemic lupus erythematosus	9.11e-07	0.000125	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	9.04e-07	0.000125	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	8.65e-07	0.000119	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	8.63e-07	0.000119	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	7.92e-07	0.000109	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	7.91e-07	0.000109	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	6.58e-07	9.06e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—systemic lupus erythematosus	5.97e-07	8.22e-05	CbGpPWpGaD
